108 related articles for article (PubMed ID: 1915551)
1. Chimeric mouse human IgG3 antibodies with an IgG4-like hinge region induce complement-mediated lysis more efficiently than IgG3 with normal hinge.
Norderhaug L; Brekke OH; Bremnes B; Sandin R; Aase A; Michaelsen TE; Sandlie I
Eur J Immunol; 1991 Oct; 21(10):2379-84. PubMed ID: 1915551
[TBL] [Abstract][Full Text] [Related]
2. C1q binding to chimeric monoclonal IgG3 antibodies consisting of mouse variable regions and human constant regions with shortened hinge containing 15 to 47 amino acids.
Sandlie I; Aase A; Westby C; Michaelsen TE
Eur J Immunol; 1989 Sep; 19(9):1599-603. PubMed ID: 2792180
[TBL] [Abstract][Full Text] [Related]
3. The extended hinge region of IgG3 is not required for high phagocytic capacity mediated by Fc gamma receptors, but the heavy chains must be disulfide bonded.
Aase A; Sandlie I; Norderhaug L; Brekke OH; Michaelsen TE
Eur J Immunol; 1993 Jul; 23(7):1546-51. PubMed ID: 8325331
[TBL] [Abstract][Full Text] [Related]
4. Activation of complement by an IgG molecule without a genetic hinge.
Brekke OH; Michaelsen TE; Sandin R; Sandlie I
Nature; 1993 Jun; 363(6430):628-30. PubMed ID: 8510754
[TBL] [Abstract][Full Text] [Related]
5. The N-terminal end of the CH2 domain of chimeric human IgG1 anti-HLA-DR is necessary for C1q, Fc gamma RI and Fc gamma RIII binding.
Morgan A; Jones ND; Nesbitt AM; Chaplin L; Bodmer MW; Emtage JS
Immunology; 1995 Oct; 86(2):319-24. PubMed ID: 7490135
[TBL] [Abstract][Full Text] [Related]
6. Structural difference in the complement activation site of human IgG1 and IgG3.
Michaelsen TE; Sandlie I; Bratlie DB; Sandin RH; Ihle O
Scand J Immunol; 2009 Dec; 70(6):553-64. PubMed ID: 19906198
[TBL] [Abstract][Full Text] [Related]
7. Studies on antigen binding by intact and hinge-deleted chimeric antibodies.
Horgan C; Brown K; Pincus SH
J Immunol; 1993 Jun; 150(12):5400-7. PubMed ID: 7685795
[TBL] [Abstract][Full Text] [Related]
8. Antibody dependent cell-mediated cytotoxicity induced by chimeric mouse-human IgG subclasses and IgG3 antibodies with altered hinge region.
Michaelsen TE; Aase A; Norderhaug L; Sandlie I
Mol Immunol; 1992 Mar; 29(3):319-26. PubMed ID: 1557042
[TBL] [Abstract][Full Text] [Related]
9. Influence of the hinge region on complement activation, C1q binding, and segmental flexibility in chimeric human immunoglobulins.
Tan LK; Shopes RJ; Oi VT; Morrison SL
Proc Natl Acad Sci U S A; 1990 Jan; 87(1):162-6. PubMed ID: 2296577
[TBL] [Abstract][Full Text] [Related]
10. Structural motifs involved in human IgG antibody effector functions.
Greenwood J; Clark M; Waldmann H
Eur J Immunol; 1993 May; 23(5):1098-104. PubMed ID: 8477804
[TBL] [Abstract][Full Text] [Related]
11. The hinge as a spacer contributes to covalent assembly and is required for function of IgG.
Coloma MJ; Trinh KR; Wims LA; Morrison SL
J Immunol; 1997 Jan; 158(2):733-40. PubMed ID: 8992989
[TBL] [Abstract][Full Text] [Related]
12. Enhancement of complement activation and cytolysis of human IgG3 by deletion of hinge exons.
Michaelsen TE; Aase A; Westby C; Sandlie I
Scand J Immunol; 1990 Nov; 32(5):517-28. PubMed ID: 2125362
[TBL] [Abstract][Full Text] [Related]
13. Human IgG isotype-specific amino acid residues affecting complement-mediated cell lysis and phagocytosis.
Brekke OH; Michaelsen TE; Aase A; Sandin RH; Sandlie I
Eur J Immunol; 1994 Oct; 24(10):2542-7. PubMed ID: 7925582
[TBL] [Abstract][Full Text] [Related]
14. Antigen binding and biological activities of engineered mutant chimeric antibodies with human tumor specificities.
Gillies SD; Wesolowski JS
Hum Antibodies Hybridomas; 1990; 1(1):47-54. PubMed ID: 2129419
[TBL] [Abstract][Full Text] [Related]
15. Effector functions of a mouse IgG that lacks the entire CH1 domain. C1q binding and complement fixation in the absence of antigen.
Mizutani R; Igarashi T; Tanaka T; Shimada I; Arata Y
J Immunol; 1993 Jan; 150(1):131-8. PubMed ID: 8417119
[TBL] [Abstract][Full Text] [Related]
16. The binding affinity of human IgG for its high affinity Fc receptor is determined by multiple amino acids in the CH2 domain and is modulated by the hinge region.
Canfield SM; Morrison SL
J Exp Med; 1991 Jun; 173(6):1483-91. PubMed ID: 1827828
[TBL] [Abstract][Full Text] [Related]
17. Improving the efficacy of antibody-interleukin 2 fusion proteins by reducing their interaction with Fc receptors.
Gillies SD; Lan Y; Lo KM; Super M; Wesolowski J
Cancer Res; 1999 May; 59(9):2159-66. PubMed ID: 10232603
[TBL] [Abstract][Full Text] [Related]
18. Biological properties of chimeric antibodies. Interaction with complement.
Boulianne GL; Isenman DE; Hozumi N; Shulman MJ
Mol Biol Med; 1987 Feb; 4(1):37-49. PubMed ID: 3613975
[TBL] [Abstract][Full Text] [Related]
19. Molecular analysis of IgM rheumatoid factor binding to chimeric IgG.
Artandi SE; Canfield SM; Tao MH; Calame KL; Morrison SL; Bonagura VR
J Immunol; 1991 Jan; 146(2):603-10. PubMed ID: 1702808
[TBL] [Abstract][Full Text] [Related]
20. Mapping of amino acid residues in the C mu 3 domain of mouse IgM important in macromolecular assembly and complement-dependent cytolysis.
Arya S; Chen F; Spycher S; Isenman DE; Shulman MJ; Painter RH
J Immunol; 1994 Feb; 152(3):1206-12. PubMed ID: 8301125
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
